摘要
采用银杏叶提取物和激素分别治疗25例儿童支气管哮喘。检测患儿治疗前后血浆血小板活化因子(PAF)水平,观察哮喘临床症状改善情况并与激素治疗组儿童血浆PAF水平比较。结果表明:银杏叶提取物治疗后,支气管哮喘患儿血浆PAF水平与激素治疗组患儿PAF水平无显著性差异(t=0.997,p>0.05),哮喘改善时间接近,银杏叶提取物可能是一种新型的预防和治疗支气管哮喘的药物。
To cure 25children bronchial asthma with Ginkgo biloba extract and hormo ne repectively.The level of blood platelet activating f actor(PAF)before and after the treatment on bro nchial asthma children with Ginkgo biloba extract was examined in a biologicalway.To o bserve the change of clinical symptoms and compare the change of bl ood PAF level between before and afte r hormone teratment.The results werethat:the children PAF l evels of the two treatments did not exist remarkable difference.(t =0.997,p >0.05),andthe time of asthma improvement was similar.Perhaps the Ginkgobilob a extract was a kind of new drug to prevent and tr eat on bronchial asthma.
出处
《食品科学》
EI
CAS
CSCD
北大核心
2003年第3期122-124,共3页
Food Science
